The Left Appendage Occlusion Device Market Size is valued at 960.0 Million in 2022 and is predicted to reach 5381.3 Million by the year 2031 at a 21.2 % CAGR during the forecast period for 2023-2031.
The left appendage occlusion device is used in procedures such as percutaneous transluminal left atrial appendage occlusion and thoracoscopic left atrial appendage closure. Left appendage occlusion device controls the electrical impulses during atrial fibrillation. During atrial fibrillation, blood clots are pumped out of the heart. This blood can form clots in the atria and LAA. This medical condition can cause a stroke. Left appendage occlusion device is an interventional device used to prevent stroke in atrial fibrillation. Left appendage occlusion device helps in reducing the risk of secondary stroke and emboli because of atrial fibrillation.
The global left appendage occlusion device market is expected to grow rapidly during the forecast period. Clinical evidence of the efficiency of left appendage occlusion devices compared to the standard therapeutic treatment such as warfarin and dabigatran increased awareness levels, and new product launches in new countries are key factors boosting the market growth. However, the complicated implantation procedures and need of experienced surgeons are restraining factors for the market. The stringent regulation procedures for the approval of devices are hindering the new product launches. The vendors focus on clinical trials for new product launches in the high potential market such as the US and the Asia Pacific.
Market Segmentation
The global left appendage occlusion device market is segmented on the basis of Types, Procedures, End-Users and region. Based on the Type, maket is devided into Endocardial LAA Devices and Epicardial LAA Devices. Secondly, as per produres, the market is segmented into Percutaneous, and Surgical. On the basis of End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Heart Clinics. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the market during the analysis of the forecast period.
Competitive Landscape
Some of The Key Players in The Left Appendage Occlusion Device Market:
- Atricure
- Biosense Webster
- Boston Scientific
- Abbott Laboratories
- Aegis Medical
- Cardia
- Lifetech Scientific
- Sentreheart
- Other Prominent Players
The Left Appendage Occlusion Device Market Report Scope
Report Attribute |
Specifications |
Market Size Value In 2022 |
USD 960.0 Million |
Revenue Forecast In 2031 |
USD 5381.3 Million |
Growth Rate CAGR |
CAGR of 21.2 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Types, By Procedure, By End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
Atricure, Biosense Webster, Boston Scientific, Abbott Laboratories, Aegis Medical, Cardia, Lifetech Scientific, and Sentreheart, and Others |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |